HOTH THERAPEUTICS INC (HOTH) Fundamental Analysis & Valuation

NASDAQ:HOTH • US44148G2049

Current stock price

0.7311 USD
-0.02 (-2.01%)
At close:
0.73 USD
0 (-0.15%)
After Hours:

This HOTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. HOTH Profitability Analysis

1.1 Basic Checks

  • In the past year HOTH has reported negative net income.
  • HOTH had a negative operating cash flow in the past year.
  • HOTH had negative earnings in each of the past 5 years.
  • In the past 5 years HOTH always reported negative operating cash flow.
HOTH Yearly Net Income VS EBIT VS OCF VS FCFHOTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -164.00%, HOTH is doing worse than 88.48% of the companies in the same industry.
  • The Return On Equity of HOTH (-202.73%) is worse than 76.44% of its industry peers.
Industry RankSector Rank
ROA -164%
ROE -202.73%
ROIC N/A
ROA(3y)-117.52%
ROA(5y)-130.19%
ROE(3y)-136.92%
ROE(5y)-155.53%
ROIC(3y)N/A
ROIC(5y)N/A
HOTH Yearly ROA, ROE, ROICHOTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HOTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOTH Yearly Profit, Operating, Gross MarginsHOTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HOTH Health Analysis

2.1 Basic Checks

  • HOTH has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HOTH has been increased compared to 5 years ago.
  • HOTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HOTH Yearly Shares OutstandingHOTH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
HOTH Yearly Total Debt VS Total AssetsHOTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • HOTH has an Altman-Z score of -12.04. This is a bad value and indicates that HOTH is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -12.04, HOTH is not doing good in the industry: 78.53% of the companies in the same industry are doing better.
  • HOTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.04
ROIC/WACCN/A
WACCN/A
HOTH Yearly LT Debt VS Equity VS FCFHOTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

2.3 Liquidity

  • A Current Ratio of 4.72 indicates that HOTH has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.72, HOTH is doing good in the industry, outperforming 62.83% of the companies in the same industry.
  • HOTH has a Quick Ratio of 4.72. This indicates that HOTH is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.72, HOTH is doing good in the industry, outperforming 63.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.72
Quick Ratio 4.72
HOTH Yearly Current Assets VS Current LiabilitesHOTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. HOTH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.33% over the past year.
EPS 1Y (TTM)32.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, HOTH will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.48% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.13%
EPS Next 2Y9.85%
EPS Next 3Y-10.48%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HOTH Yearly Revenue VS EstimatesHOTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
HOTH Yearly EPS VS EstimatesHOTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. HOTH Valuation Analysis

4.1 Price/Earnings Ratio

  • HOTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year HOTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOTH Price Earnings VS Forward Price EarningsHOTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOTH Per share dataHOTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • HOTH's earnings are expected to decrease with -10.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.85%
EPS Next 3Y-10.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HOTH Dividend Analysis

5.1 Amount

  • HOTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HOTH Fundamentals: All Metrics, Ratios and Statistics

HOTH THERAPEUTICS INC

NASDAQ:HOTH (5/1/2026, 8:00:02 PM)

After market: 0.73 0 (-0.15%)

0.7311

-0.02 (-2.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength67.7
Industry Growth15.53
Earnings (Last)03-27
Earnings (Next)05-11
Inst Owners6.07%
Inst Owner Change0%
Ins Owners3.41%
Ins Owner Change0%
Market Cap13.99M
Revenue(TTM)N/A
Net Income(TTM)-12.47M
Analysts82.86
Price Target5.1 (597.58%)
Short Float %30.81%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-125.49%
Min EPS beat(2)-194.12%
Max EPS beat(2)-56.86%
EPS beat(4)0
Avg EPS beat(4)-67.96%
Min EPS beat(4)-194.12%
Max EPS beat(4)-1.81%
EPS beat(8)3
Avg EPS beat(8)-25.7%
EPS beat(12)7
Avg EPS beat(12)-8.02%
EPS beat(16)10
Avg EPS beat(16)-4.53%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 2.27
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -164%
ROE -202.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.52%
ROA(5y)-130.19%
ROE(3y)-136.92%
ROE(5y)-155.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.72
Quick Ratio 4.72
Altman-Z -12.04
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y33.13%
EPS Next 2Y9.85%
EPS Next 3Y-10.48%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-50.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.49%
OCF growth 3YN/A
OCF growth 5YN/A

HOTH THERAPEUTICS INC / HOTH Fundamental Analysis FAQ

What is the fundamental rating for HOTH stock?

ChartMill assigns a fundamental rating of 2 / 10 to HOTH.


What is the valuation status of HOTH THERAPEUTICS INC (HOTH) stock?

ChartMill assigns a valuation rating of 0 / 10 to HOTH THERAPEUTICS INC (HOTH). This can be considered as Overvalued.


What is the profitability of HOTH stock?

HOTH THERAPEUTICS INC (HOTH) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for HOTH stock?

The Earnings per Share (EPS) of HOTH THERAPEUTICS INC (HOTH) is expected to grow by 33.13% in the next year.